What is the appropriate management for a 19‑month‑old child with frequent vomiting for the past two days and foul‑smelling yellowish loose stools?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of 19-Month-Old with Vomiting and Loose Stools

This child most likely has acute gastroenteritis and requires immediate assessment of hydration status followed by oral rehydration therapy (ORS) as first-line treatment. 1

Immediate Assessment Priority

Evaluate the child's hydration status and look for these specific red flags:

  • Altered mental status or lethargy
  • Signs of severe dehydration (sunken eyes, decreased skin turgor, dry mucous membranes, reduced urine output)
  • Bilious (green) vomiting
  • Blood in vomit or stool
  • Severe abdominal distension or tenderness
  • Toxic appearance or signs of sepsis 2, 3

Treatment Algorithm Based on Hydration Status

If Mild to Moderate Dehydration (Most Likely Scenario):

Start oral rehydration solution (ORS) immediately - this is the gold standard and saves lives. 1 The hypotonic ORS formulation (osmolarity <250 mmol/L) is superior to older formulations and should be given until clinical dehydration resolves.

  • Continue breastfeeding if still nursing throughout the illness 1
  • Resume normal age-appropriate diet immediately once rehydration begins - do not withhold food for 24 hours as this is outdated practice 1
  • Early feeding (within 12 hours) improves nutritional outcomes and does not worsen symptoms

For Persistent Vomiting Interfering with Oral Intake:

Consider ondansetron ONLY if the child is >4 years old according to guideline recommendations 1. However, since your child is only 19 months old, ondansetron is NOT recommended per the strongest guideline evidence 1.

Important caveat: While research studies 4, 2, 5 show ondansetron (0.2 mg/kg oral, max 4 mg) can reduce vomiting and IV fluid needs in younger children, the 2017 IDSA guidelines specifically state it "may be given to facilitate tolerance of oral rehydration in children >4 years of age" 1. This represents a conservative guideline stance despite supportive research evidence. The research shows ondansetron increases diarrhea episodes as a trade-off 6, 5.

If the child cannot tolerate oral ORS due to vomiting, consider nasogastric tube administration of ORS before resorting to IV fluids 1.

If Severe Dehydration or Red Flags Present:

Immediate IV rehydration with isotonic fluids (lactated Ringer's or normal saline) is required if there is:

  • Severe dehydration
  • Shock
  • Altered mental status
  • Failure of ORS therapy
  • Bilious vomiting (suggests obstruction - requires immediate surgical consultation) 1, 2

Continue IV fluids until pulse, perfusion, and mental status normalize, then switch to ORS for remaining deficit 1.

Specific Considerations for This Case

The foul-smelling yellowish loose stools suggest infectious gastroenteritis, most commonly viral. The stool character described does not suggest blood or severe inflammatory diarrhea, which is reassuring.

Do NOT give antimotility drugs (loperamide) - these are contraindicated in all children <18 years with acute diarrhea 1.

Probiotics may be offered to reduce symptom duration and severity, though this is a weak recommendation 1.

Common Pitfalls to Avoid

  • Do not withhold food - the BRAT diet and 24-hour fasting are outdated practices with limited supporting data 1
  • Do not use antiemetics as substitute for rehydration - fluid replacement is the cornerstone of treatment 1
  • Do not routinely order laboratory tests unless there are red flags or signs of severe dehydration 2
  • Do not give ondansetron to children <4 years per guidelines, despite research showing potential benefit in younger ages 1

Ongoing Management

  • Replace ongoing stool losses with ORS until diarrhea and vomiting resolve 1
  • Monitor for worsening dehydration over the next 24-48 hours
  • Ensure proper hand hygiene after diaper changes and before food preparation to prevent spread 1

The vast majority of these cases resolve with supportive care within 3-5 days. Seek immediate medical attention if red flags develop or dehydration worsens despite ORS therapy.

References

Research

Management of a child with vomiting.

Indian journal of pediatrics, 2013

Research

Child with Vomiting.

Indian journal of pediatrics, 2017

Research

Antiemetic Drug Use in Children: What the Clinician Needs to Know.

Journal of pediatric gastroenterology and nutrition, 2019

Related Questions

What are the Indian Academy of Pediatrics (IAP) guidelines for the use of antiemetics in children with vomiting?
What is the appropriate evaluation and management for an 8‑year‑old with four days of vomiting, no fever, lower abdominal pain, and a negative urinalysis?
What medication is indicated for a 3‑month‑old infant with post‑tussive emesis and clear lung fields?
What guidance should be given to parents for managing nausea and vomiting in a child with no abnormal findings?
What anti‑emetic suppository is appropriate for a 1‑year‑old child with vomiting?
How should I manage a 75‑year‑old male two weeks after left total knee arthroplasty who presents with orthostatic hypotension, anemia, leukocytosis, thrombocytosis, hypoalbuminemia, significant insomnia with restless‑leg syndrome, and is currently taking apixaban (Eliquis), losartan, hydrochlorothiazide (held), iron supplement, acetaminophen, rosuvastatin, magnesium glycinate, and tizanidine?
Is it safe to take famotidine at night and omeprazole in the morning?
A 50‑year‑old female with a 1 cm estrogen‑receptor‑positive invasive ductal carcinoma, no nodal involvement, Oncotype DX score 7, currently on an aromatase inhibitor, presents with eye, lip, limb and buttock fasciculations, weight gain, dyspnea, dysphagia‑like sensation, peripheral tingling after exercise, and anxiety about aromatase inhibitors; what is the recommended management regarding endocrine therapy, evaluation of these symptoms, and weight‑loss strategy?
How should a serum calcium of 7.9 mg/dL be evaluated and managed?
What is the recommended treatment for pseudofolliculitis pubis?
In a 50‑year‑old woman with estrogen‑receptor‑positive invasive ductal carcinoma (node‑negative, Oncotype DX score 7) on an aromatase inhibitor who now has widespread fasciculations, mild weight gain, dyspnea, dysphagia‑like sensation, exercise‑induced peripheral tingling, and a normal neurologic exam, is an ALS workup indicated?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.